Nuwellis, Inc. (NUWE): Nasdaq/NYSE listing notice — Nuwellis receives Nasdaq delisting notice for bid price below $1.00; plans reverse split and hearing

Nuwellis, Inc.

Received Nasdaq Deficiency Notice on June 18, 2025 for failure to meet $1.00 minimum bid price requirement.
Not eligible for standard compliance period due to prior reverse stock splits totaling at least 250:1 over two years.
Intends to request a hearing and effect a reverse stock split (approved 1:5 to 1:70 at May 20, 2025 meeting) to regain compliance.
No assurance of continued listing; securities remain listed pending final hearing conclusion.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Nuwellis, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

June 18, 2025, Nuwellis, Inc. (the “Company” ) received a letter (the “Deficiency Notice” ) from the Listing Qualifications Department (the “Staff” ) of the Nasdaq Stock Market ( “Nasdaq” ) informing the Company that because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Marketplace Rule 5550(a)(2) (the “Minimum Bid Price Requirement” ). The Deficiency Notice also indicated th

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Nuwellis, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-25-023368

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.